Advanced Enzyme allots shares worth Rs122.85 crore ahead of IPO
Advanced Enzyme has fixed a price band of Rs880-896 per share for its IPO and is looking to raise around Rs412 crore through the share sale
Mumbai: Advanced Enzyme Technologies Ltd on Tuesday said that it has allotted shares worth Rs.122.85 crore as part of the anchor book allotment ahead of its initial public offering (IPO).
The anchor book is that portion of the IPO which bankers can allot to institutional investors on a discretionary basis. Anchor book subscription opens a day before the launch of an IPO and acts as an indicator of institutional investor interest.
Advanced Enzyme’s IPO opens on Wednesday and closes on Friday. The company has fixed a price band of Rs.880-896 per share. It is looking to raise around Rs.412 crore, including the anchor portion, through the share sale.
Advanced Enzyme is engaged in the manufacture, marketing, research and development of 400-plus proprietary products developed from enzymes. Shares were allotted to the anchor investors at the upper end of the price band of Rs.896 per share.
A total of 15 institutional investors participated in the company’s anchor book allocation. DB International (Asia) Ltd and Kuwait Investment Authority, the sovereign wealth fund of Kuwait, were the foreign investors. HDFC Mutual Fund, Reliance Capital, ICICI Prudential Life Insurance, SBI Life Insurance, Birla Sun Life and L&T Mutual Fund were among the domestic investors who picked up a stake in the anchor book allotment.
The public offering of Advanced Enzyme is a mix of primary fund-raising and a secondary share sale by existing investors of the company. The company is looking at raising Rs.50 crore in primary capital through the IPO, which will be used for investment in Advanced Enzymes USA, its subsidiary, for repayment of certain loans.
In the financial year 2015-16, the company reported a revenue of Rs.294.6 crore, up from Rs.224.2 crore the previous year. In 2015-16, its profit stood at Rs.78.4 crore, up from Rs.50.1 crore the previous financial year.
Advanced Enzyme’s share sale comes at a time when the IPO market has seen significant momentum in the last few weeks. On 1 July, the IPO of integrated business services provider Quess Corp. Ltd (QCL) received subscriptions that were 144.31 times the issue size of Rs.400 crore, registering the fifth highest overall subscription (in percentage terms) for any IPO since 2000.
Last week, L&T Infotech Ltd’s Rs.1,243 crore IPO was subscribed more than 11 times.
So far this year, 13 companies have raised around Rs.9,425.5 crore through IPOs, while last year 21 firms raised Rs.13,614 crore from their initial share sales, according to data from Prime Database, a primary market tracker.